Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open‐Label Randomized Controlled Trial

Marjan Ghiti Moghadam, Harald E. Vonkeman, Peter M. ten Klooster, Janneke Tekstra, Dirk-Jan van Schaardenburg, Mirian Starmans-Kool, Elisabeth Brouwer, Reinhard Bos, Willem F. Lems, Edgar M. Colin, Cornelia F. Allaart, Inger L. Meek, Robert Landewe, Hein J. Bernelot Moens, Piet L.C.M. van Riel, Mart A.F.J. van de Laar, Tim L. Jansen

Research output: Contribution to journalArticleAcademicpeer-review

48 Citations (Scopus)
135 Downloads (Pure)

Fingerprint Dive into the research topics of 'Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open‐Label Randomized Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences